Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255 64. 113. Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens (Greenwich). 2008;10:20 6. 114. van der Laan DM, Elders PJM, Boons CCLM, et al. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens. 2017;31:687 94. 115. Claxton AJ, Cramer J, Pierce C. A systematic review of the associa- tions between dose regimens and medication compliance. Clin Ther. 2001;23:1296 310. 116. Iskedjian M, Einarson TR, MacKeigan LD, et al. Relationship between dai- ly dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002;24:302 16. 117. Kim MT, Hill MN, Bone LR, et al. Development and testing of the Hill- Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15:90 6. 118. Pharmacy Quality Alliance. Available at: https://www.pqaalliance.org/. Accessed July 15, 2019. 119. National Center for Chronic Disease Prevention and Health Promotion. Calculating proportion of days covered (PDC) for antihypertensive and antidiabetic medications: an evaluation guide for grantees. Available at: https://www.cdc.gov/dhdsp/docs/med-adherence-evaluation-tool.pdf. Accessed July 15, 2019. 120. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164: 722 32. 121. Xu W, Goldberg SI, Shubina M, et al. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study. BMJ. 2015;350:h158. 122. Czernichow S, Zanchetti A, Turnbull F, et al. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertens. 2011;29:4 16. 123. Thompson AM, Hu T, Eshelbrenner CL, et al. 